Ultrastructural evidence of the mechanisms responsible for interleukin‐4‐activated rejection of a spontaneous murine adenocarcinoma
- 1 April 1993
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 53 (6) , 988-993
- https://doi.org/10.1002/ijc.2910530622
Abstract
The ultrastructural pattern of the anti‐tumor response elicited by interleukin‐4 (IL‐4) was investigated by using a spontaneous mammary adenocarcinoma (TS/A) unable to elicit protective immunity in syngeneic BALB/c mice as suggested by a variety of preimmunization‐challenge experiments. A subcutaneous lethal challenge of TS/A tumor cells was inhibited in a significant number of BALB/c mice receiving recombinant murine IL‐4 injected daily for 10 days around the tumor‐draining lymph node. Tumor rejection was mainly the result of direct membrane and cytoplasmic damage to tumor cells by eosinophils, neutrophils and macrophages that deeply penetrated the proliferating tumor mass. Lymphocytes and fibroblasts participated in the reaction by interacting with tumor cells, granulocytes and each other. The most frequent cell interactions in the peri‐ and intra‐tumoral areas and in the tumor‐draining lymph nodes are illustrated. The efficiency with which the IL‐4‐activated reaction leads to tumor inhibition and induction of a T‐lymphocyte‐dependent tumor‐specific immune memory appears to depend on interactions between distinct leukocytes.Keywords
This publication has 21 references indexed in Scilit:
- An Eosinophil-Dependent Mechanism for the Antitumor Effect of Interleukin-4Science, 1992
- Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4Science, 1991
- Cytokines and cancer: experimental systemsCurrent Opinion in Immunology, 1991
- Cytokines in context.The Journal of cell biology, 1991
- Properties of the Novel Proinflammatory Supergene "Intercrine" Cytokine FamilyAnnual Review of Immunology, 1991
- Tumor-associated macrophagesCurrent Opinion in Immunology, 1990
- Murine interleukin-4 displays potent anti-tumor activity in vivoCell, 1989
- Lymphokine-activated tumor inhibition: Combinatory activity of a synthetic nonapeptide from interleukin-1, interleukin-2, interleukin-4, and interferon-γ injected around tumor-draining lymph nodesInternational Journal of Cancer, 1989
- B-Cell Stimulatory Factor-1/Interleukin 4Annual Review of Immunology, 1987
- ANTIGEN-PULSED NEUTROPHILS BEARING Ia ANTIGENS CAN INDUCE T LYMPHOCYTE PROLIFERATIVE RESPONSE TO THE SYNGENEIC OR SEMISYNGENEIC ANTIGEN-PRIMED T LYMPHOCYTESTransplantation, 1980